Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case.
10.9758/cpn.2017.15.3.282
- Author:
Ozalp EKINCI
1
;
Serkan GUNES
;
Nuran EKINCI
Author Information
1. Department of Child and Adolescent Psychiatry, Mersin University School of Medicine, Mersin, Turkey. ozalpekinci@yahoo.com
- Publication Type:Case Report
- Keywords:
Galactorrhea;
Methylphenidate;
Selective serotonin reuptake inhibitors;
Adolescent
- MeSH:
Adolescent*;
Antipsychotic Agents;
Female;
Galactorrhea*;
Haloperidol;
Humans;
Methylphenidate*;
Pregnancy;
Serotonin Uptake Inhibitors;
Sertraline
- From:Clinical Psychopharmacology and Neuroscience
2017;15(3):282-284
- CountryRepublic of Korea
- Language:English
-
Abstract:
Galactorrhea, as an adverse effect of psychotropic medications, usually develops due to high dose of antipsychotics. Selective serotonin reuptake inhibitors (SSRIs) have also been reported to be related to galactorrhea. To the best of our knowledge, no previous study reported galactorrhea with methylphenidate (MPH) use. Hereby, we report a case of an adolescent girl who developed galactorrhea after increasing his modifed-release oral MPH to 50 mg/day while under treatment of sertraline and very low dose haloperidol.
